Abstract Submission

Abstract Submission for WISC 2012 Scientific Program CLOSED

The World Allergy Organization invites you to submit an abstract to be considered for inclusion in the Scientific Program of the 2012 WAO International Scientific Conference. Accepted abstracts will be presented during thematic Poster Sessions on 7, 8 and 9 December 2012.

Please carefully read the Abstract Guidelines below before submitting an abstract. Abstracts can be submitted only electronically through this web page.

It is the author's responsibility to submit a correctly edited and accurate abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive detailed presentation guidelines when their abstract has been accepted.

Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author's e-mail address immediately upon submission.

Abstract Guidelines

  • The abstract must be written and presented in English.
  • Abstracts must contain original data and meet international ethical standards.
  • A maximum of three abstracts may be submitted by the same Presenting Author.
  • An abstract cannot be submitted to more than one thematic category.
  • Case reports that include findings that are significant and have applied appropriate statistical and analytical methods will be considered for presentation. All other case reports will not be accepted for oral or poster presentation.
  • Previously published and presented abstracts can be submitted.
  • Use a maximum of 2,500 characters (approximately 350 words) including blank spaces for the abstract text.
  • The Abstract Title must have the first letter of each word capitalized.
  • Tables and graphs should not be included in the abstract.
  • References (maximum of 2) can be included in the body of the text.
  • The abstract title and the author(s) or names of institutions are not to be included in the abstract text.
  • Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time the full wording appears in the body of the text.
  • Non-proprietary (generic) names of drugs, written in lower case, are required at the first mention of a drug.
  • Trade names are not allowed
  • Late-breaking abstracts MUST be of high quality, represent an important research advance and present information that was not available at the time of regular abstract submission.
  • These abstracts must present information that is significant to clinical, translational or basic science, novel, uses appropriate study design, analytical methods and statistical methods and is clearly and logically written.
  • Submitters will be required to explain why their abstract is important or late breaking.
  • Abstracts submitted only because they missed the initial deadline for regular abstracts will not be considered.
  • Late Breaking Abstracts are competitively reviewed.

Organization of the Abstract

In order to make the abstract as informative as possible, please provide:

  • a brief statement of the purpose of the study
  • the method used
  • the result observed
  • the conclusions based upon the results

It is inadequate to state "The results will be discussed" or "The data will be presented."

We kindly ask you to subtitle the paragraphs in bold format in the following order: Background, Method, Results, and Conclusions.

A) Background: A statement of purpose of the study (preferably one sentence).

B) Methods: A brief statement of the methods used. For abstracts reporting clinical research, a sentence or phrase presenting the most important selection criteria for subjects should be included.

C) Results: A summary of the results presented in sufficient detail with statistical analysis to support the conclusions.

D) Conclusions: A statement of the conclusions reached. It is not satisfactory to state, "the results will be discussed," or "other data will be presented," etc.

Abstract Revisions

Changes to abstracts are accepted only until the submission deadline by using the abstract submission website.

Abstract Submission Disclosure Policy

WAO requires that Presenting Authors submit all Conflict of Interest Disclosures for CME compliance purposes.

Publication of Abstracts

Accepted abstracts will be published in the WAO Journal in the February 2013 issue.

Notification of Acceptance

Notification of acceptance/rejection will be emailed by the end of September, 2012. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time.

Registration and Payment

The Presenting Author must register for the Conference and pay the registration fee before 15 October 2012. Abstracts will be automatically withdrawn if the Presenting Author is not registered.

The Presenting Author of an accepted abstract is allowed to register with the Early Registration Fee until 15 October 2012. Full registration refunds will be given to Presenting Authors of abstracts that are not accepted.


Abstract presenters are responsible for arranging and paying for their own registration, travel and hotel arrangements.

Attendance of Presenters

WAO cannot guarantee that those Presenting Authors who do not show up during the session will be accepted for abstract presentations at future meetings.